Harmony Biosciences Holdings, Inc. revenue breakdown overview

Harmony Biosciences Holdings, Inc. revenue for the last year amounted to 714.73 M USD, the most of which — 714.73 M USD — came from its highest performing source at the moment, Rare Neurological Diseases, the year earlier bringing 582.02 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Harmony Biosciences Holdings, Inc. 714.73 M USD, and the year before that — 582.02 M USD.